What is a stock summary page? Click here for an overview.
Current and historical daily PS Ratio for Polynovo Ltd (
) from 1998 to Apr 25 2025. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Polynovo stock (ASX:PNV) PS ratio as of Apr 25 2025 is 7.05.
More Details
Polynovo Ltd (ASX:PNV) PS Ratio Chart
Polynovo Ltd (ASX:PNV) PS Ratio Historical Data
View and export this data going back to 1998. Start your Free Trial
Total 1250
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Polynovo PS Ratio Historical Data | |||
|---|---|---|---|
| Date | PS Ratio Data | Date | PS Ratio Data |
| 2025-04-26 | 6.9 | 2025-02-19 | 11.3 |
| 2025-04-24 | 6.9 | 2025-02-18 | 11.3 |
| 2025-04-23 | 6.7 | 2025-02-17 | 11.6 |
| 2025-04-22 | 6.2 | 2025-02-14 | 11.3 |
| 2025-04-17 | 6.6 | 2025-02-13 | 11.1 |
| 2025-04-16 | 6.2 | 2025-02-12 | 10.5 |
| 2025-04-15 | 6.5 | 2025-02-11 | 10.7 |
| 2025-04-14 | 6.5 | 2025-02-10 | 11.1 |
| 2025-04-11 | 6.1 | 2025-02-07 | 11.2 |
| 2025-04-10 | 6.3 | 2025-02-06 | 11.4 |
| 2025-04-09 | 5.7 | 2025-02-05 | 11.5 |
| 2025-04-08 | 6.2 | 2025-02-04 | 11.6 |
| 2025-04-07 | 5.7 | 2025-02-03 | 11.4 |
| 2025-04-04 | 6.2 | 2025-01-31 | 12.3 |
| 2025-04-03 | 6.5 | 2025-01-30 | 12.5 |
| 2025-04-02 | 6.7 | 2025-01-29 | 12.9 |
| 2025-04-01 | 6.8 | 2025-01-28 | 12.9 |
| 2025-03-31 | 6.7 | 2025-01-27 | 13.2 |
| 2025-03-28 | 7.0 | 2025-01-24 | 13.2 |
| 2025-03-27 | 7.3 | 2025-01-23 | 13.5 |
| 2025-03-26 | 7.3 | 2025-01-22 | 13.5 |
| 2025-03-25 | 7.5 | 2025-01-21 | 13.3 |
| 2025-03-24 | 7.5 | 2025-01-20 | 12.9 |
| 2025-03-21 | 7.5 | 2025-01-17 | 13.0 |
| 2025-03-20 | 7.7 | 2025-01-16 | 12.7 |
| 2025-03-19 | 7.3 | 2025-01-15 | 12.3 |
| 2025-03-18 | 7.5 | 2025-01-14 | 12.7 |
| 2025-03-17 | 7.4 | 2025-01-13 | 11.9 |
| 2025-03-14 | 7.2 | 2025-01-10 | 12.2 |
| 2025-03-13 | 6.9 | 2025-01-09 | 12.2 |
| 2025-03-12 | 6.9 | 2025-01-08 | 12.1 |
| 2025-03-11 | 6.8 | 2025-01-07 | 12.1 |
| 2025-03-10 | 7.4 | 2025-01-06 | 12.1 |
| 2025-03-07 | 7.1 | 2025-01-03 | 11.9 |
| 2025-03-06 | 8.1 | 2025-01-02 | 12.1 |
| 2025-03-05 | 8.2 | 2025-01-01 | 12.0 |
| 2025-03-04 | 8.4 | 2024-12-31 | 12.0 |
| 2025-03-03 | 8.7 | 2024-12-30 | 12.3 |
| 2025-02-28 | 8.4 | 2024-12-27 | 14.3 |
| 2025-02-27 | 8.7 | 2024-12-24 | 13.9 |
| 2025-02-26 | 8.3 | 2024-12-23 | 13.7 |
| 2025-02-25 | 8.7 | 2024-12-20 | 13.0 |
| 2025-02-24 | 10.5 | 2024-12-19 | 13.4 |
| 2025-02-21 | 11.5 | 2024-12-18 | 14.1 |
| 2025-02-20 | 11.2 | 2024-12-17 | 13.9 |
Polynovo Ltd (ASX:PNV) PS Ratio Comparison
| Company | Market Cap(Mil) | PS Ratio |
|---|
Business Description
Business Description
Polynovo Ltd
NAICS : 325413
SIC : 2835
ISIN : AU000000PNV0
Description
Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers